Clinical Trial Update: Pharmacogenetics, Emotional Reactivity and Smoking [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 clinical trial update investigating pharmacogenetics and emotional reactivity in smoking cessation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smoking Cessation
• Tobacco Use Disorder

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Tobacco Use Disorder, Smoking Cessation | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2021-05-06